title: Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
authors.affiliation: Department of Surgery, University Hospital Freiburg im Breisgau, West Germany.
authors.forename: M
authors.initials: M
authors.lastname: Blümke
authors.forename: G
authors.initials: G
authors.lastname: Kirste
authors.forename: U
authors.initials: U
authors.lastname: Wanner
authors.forename: H
authors.initials: H
authors.lastname: Wilms
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011897:Random Allocation; D013256:Steroids / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D013256:Steroids; D001379:Azathioprine